Chemed (NYSE: CHE) director sells 190 shares at $532 in open trade
Rhea-AI Filing Summary
Chemed Corp director Patrick P. Grace reported a sale of 190 shares of Capital Stock on 2026-07-31 at $532.00 per share in an open market or private transaction. After this sale, he directly owns 3,533 shares of Chemed stock. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 190 shares
Net Sell
1 txn
Insider
GRACE PATRICK P
Role
Director
Sold
190 shs ($101K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Capital Stock | 190 | $532.00 | $101K |
Holdings After Transaction:
Capital Stock — 3,533 shares (Direct)
Key Figures
Shares sold: 190 shares
Sale price per share: $532.00
Shares owned after transaction: 3,533 shares
+1 more
4 metrics
Shares sold
190 shares
Capital Stock sale on 2026-07-31 by director Patrick P. Grace
Sale price per share
$532.00
Price for the sale in open market or private transaction
Shares owned after transaction
3,533 shares
Direct holdings following the reported sale
Net shares sold
190 shares
Net-sell shares in the transaction summary
Key Terms
Capital Stock, Sale in open market or private transaction, Form 4
3 terms
Capital Stock financial
"security title reported as "Capital Stock" in the transaction"
Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.
Sale in open market or private transaction financial
"transaction code description "Sale in open market or private transaction""
Form 4 regulatory
"insider transaction reported on SEC Form 4 for Chemed Corp"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Chemed (CHE) director Patrick P. Grace report?
Patrick P. Grace reported selling 190 shares of Chemed Capital Stock on 2026-07-31 at $532.00 per share. The sale was classified as a “sale in open market or private transaction,” and his direct holdings fell to 3,533 shares afterward.
Was the Chemed (CHE) insider sale made under a Rule 10b5-1 trading plan?
The filing does not classify this sale as made under a Rule 10b5-1 trading plan. The document-level 10b5-1 checkbox is not marked as an affirming plan trade, indicating the transaction was not reported as pre-arranged under such a plan.
What is the size of the Chemed (CHE) insider sale in this Form 4?
The Form 4 reports a sale of 190 shares of Chemed Capital Stock at $532.00 per share. This single non-derivative transaction is the only trade disclosed, classified as a sale in an open market or private transaction by a company director.